|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues, net | |||||
| Costs and expenses | |||||
| Cost of revenues | |||||
| General and administrative expenses | |||||
| Impairment loss - note receivable | |||||
| Impairment loss - CenterCom | |||||
| Impairment loss - internal use software development costs | |||||
| Impairment loss - goodwill | |||||
| Total costs and expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest expense | |||||
| Amortization of debt discount | |||||
| Interest expense (including amortization of debt discount) | |||||
| Loss on lease termination - net | |||||
| Other income | |||||
| Interest income | |||||
| Realized gains - investments | |||||
| Dividends, interest and other income - investments | |||||
| Gain on investment in CenterCom | |||||
| Total other income (expense) - net | |||||
| Net loss before provision for income taxes | |||||
| Provision for income tax benefit (expense) | |||||
| Net loss including non-controlling interest | |||||
| Non-controlling interest | |||||
| Net loss available to common stockholders | |||||
| Loss per share - attributable to common stockholders | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average number of shares outstanding - attributable to common stockholders | |||||
| Basic | |||||
| Diluted | |||||
Loading...